Most cited papers from HM Hospitales

The most cited paper from HM Hospitales is "Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial" (Robert Louis Coleman et al., 2017), with 1,729 citations. Next come "Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group" (1,221) and "Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer" (944).

Showing 50 of 59 papers. Every paper with more than 103 citations is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.